In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Myriad Genetics awarded US patent
Myriad Genetics awarded hypertension patent
Myriad Genetics Awarded $14.2 Million by NIH for Pathogen Drug and Diagnostic Development
Myriad Genetics Selects Lundbeck as European Partner for Flurizan
Myriad Genetics is exclusive licensee of New Mayo Clinic patent on amyloid lowering drugs
Myriad Genetics forms new subsidiary to develop lead compounds
Maxim Pharmaceuticals licenses novel cancer therapeutic candidate to Myriad Genetics
Myriad Genetics expands collaboration with Schering AG
Myriad Genetics and Searle expand drug discovery alliance
Myriad Genetics forms alliance with Biotecne for familial disease genomics
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
